Semax in Neuropeptide Research requires traceable specification (5mg / 10mg) and RUO acknowledgment; Semax Catalog Comparison Notes outlines buyer steps on sulanpeptide.vip.
Semax is a synthetic ACTH-derived heptapeptide used in laboratory research on neuropeptide signaling, melanocortin-related pathway models, peptide stability, and cellular response studies.
Institute of Molecular Genetics ( Moscow ) publications established Semax in cerebral ischemia research models as a neuroactive peptide probe. Semax is an ACTH(4-10) analog studied for neurotrophic effects involving BDNF upregulation and dopaminergic pathway modulation in stroke and hypoxia rodent models.
Heptapeptide lacks corticotropic activity of full ACTH while retaining CNS signaling properties in blood–brain barrier penetration research. Morris water maze performance, infarct volume histology (TTC staining), and BDNF ELISA from brain homogenates are recurring experimental endpoints.
Catalog comparison: Compare Semax (5mg / 10mg) on vial format, documented purity, and COA access—not product name alone. Related Neuropeptide Research items include DSIP, KissPeptin-10, PT-141, Selank. Export spec fields before leadership approval.
Single-peptide and blend formats serve different experimental designs; confirm protocol needs before selecting Semax.
Catalog identifiers for Semax: CAS 80714-61-0, Formula: C37H51N9O10S. MW 813.9 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Listed formats for Semax: 5mg10vials, 10mg10vials. Quote emails should include Cat No. (XA5, XA11) so delivered vials match protocol design.
When citing external effect sizes for Semax, match mg strength to published studies.
Price-per-mg comparisons for Semax should include documentation and shipping—not vial price alone.
Price-per-mg analysis for Semax should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone. Peer products in Neuropeptide Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for Semax.
Catalog comparison for Semax within Neuropeptide Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs. Semax (5mg / 10mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials.
Literature effect sizes for Semax experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names.
Semax (5mg / 10mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials. Literature effect sizes for Semax experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names.
Catalog comparison for Semax within Neuropeptide Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs.
Literature effect sizes for Semax experiments often cite specific mg strengths. When comparing suppliers, align delivered specification with published methods—not approximate product names. Price-per-mg analysis for Semax should include documentation access, shipping cost, and repeat-order batch continuity—not headline vial price alone.
Peer products in Neuropeptide Research may differ by receptor target or sequence length even when names sound similar. Mechanism fit review precedes price comparison for Semax. Catalog comparison for Semax within Neuropeptide Research should export specification fields into a spreadsheet: mg strength, Cat No., purity target, COA availability, and format. Leadership reviews proceed faster with aligned columns than with sequential product tabs.
Semax (5mg / 10mg) may compete with single-peptide and blend SKUs in the same research direction. Match protocol design—factorial versus monotherapy—before selecting a catalog line; blends cannot be deconvolved post hoc without separate vials.
Semax from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.